Telehealth General Psychiatry Prescribing: What PMHNPs Can Do in Illinois

You’ve built a psychiatric practice that works. Patients are getting better. Your schedule is full. But here’s the thing — you could be seeing twice as many patients if you weren’t limited by geography and office overhead.

Telehealth has fundamentally changed psychiatry. The question isn’t whether you should prescribe via telehealth — it’s whether you legally can, and what the rules actually are in your state.

Let’s cut through the confusion. Whether you’re a psychiatrist, PMHNP, or prescriber exploring telepsychiatry, this guide covers everything you need to know about prescribing medications remotely — including the controlled substances that make up a huge portion of psychiatric care.

The Short Answer: Yes, Psychiatrists Can Prescribe Via Telehealth (With Important Caveats)

As of 2026, psychiatrists can prescribe nearly all psychiatric medications through telehealth, including controlled substances like ADHD stimulants and benzodiazepines. This is thanks to federal emergency waivers that remain in effect through December 31, 2025, and state laws that have largely embraced telepsychiatry.

But here’s where it gets tricky: your scope depends on your credentials and the state where your patient is located. A psychiatrist (MD/DO) has full prescribing authority nationwide. A psychiatric nurse practitioner? That depends entirely on state law — and the rules vary dramatically.

The regulatory landscape is also shifting. The DEA has proposed new rules that could reimpose in-person visit requirements for controlled substances, so staying current isn’t optional — it’s essential for compliance.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Understanding the Federal Framework: The Ryan Haight Act and COVID-Era Waivers

Normally, federal law (the Ryan Haight Act) requires an in-person medical evaluation before prescribing controlled substances. This was a major barrier to telepsychiatry — imagine not being able to start a new ADHD patient on Adderall without seeing them face-to-face first.

Then COVID hit. In March 2020, the DEA issued emergency waivers allowing providers to prescribe controlled substances via telehealth without an initial in-person visit. These waivers have been extended multiple times and remain in effect through at least December 31, 2025.

What this means practically:

• You can initiate controlled substance prescriptions (stimulants, benzodiazepines, buprenorphine) via video visit for new patients
• Follow-up prescriptions for ongoing patients can continue via telehealth
• The standard of care still applies — you must conduct a thorough evaluation via secure video, document appropriately, and ensure the patient-provider relationship is legitimate

Important: The DEA has proposed permanent rules that would require either (1) an in-person visit with another provider in the past 12 months, (2) a 30-day limit on initial prescriptions, or (3) special registration. These rules haven’t been finalized as of early 2026, but watch for updates by late 2024. Until then, the emergency flexibilities remain.

State-Specific Rules: Where the Real Complexity Lives

Federal law sets the floor, but states can impose additional restrictions. Some states have carved out explicit exceptions for psychiatric treatment; others mirror federal rules; a few are more restrictive.

Florida: Explicitly Permits Teleprescribing for Psychiatric Treatment

Florida statute (F.S. 456.47) specifically allows controlled substances to be prescribed via telehealth for the treatment of psychiatric disorders. This is a notable exception — Florida prohibits teleprescribing opioids for chronic pain but makes a carve-out for mental health.

If you’re a Florida-licensed psychiatrist, you can:

• Prescribe ADHD stimulants, benzodiazepines, and other psychiatric controlled substances via video visit
• Do so for new patients without an in-person exam (under current federal allowances)
• Treat across the full spectrum of psychiatric conditions remotely

Catch for PMHNPs: Florida’s ‘autonomous practice’ law (HB 607, 2020) applies only to primary care NPs — psychiatric NPs were excluded. PMHNPs in Florida still need a supervising psychiatrist and a written protocol to prescribe, even via telehealth. If you’re a ‘psychiatric nurse’ (PMHNP with 2+ years experience under an MD), you can prescribe psychotropic controlled substances in collaboration with a psychiatrist, but you can’t practice independently.

Texas: Allows Psychiatric Telehealth Prescribing (But Not Chronic Pain)

Texas modernized its telemedicine laws in 2017 (SB 1107). The state allows prescribing controlled substances via telehealth for psychiatric conditions, as long as you conduct a valid telemedicine encounter (real-time audio-visual interaction) that meets the standard of care.

What Texas prohibits:

• Teleprescribing Schedule II opioids for chronic pain (that requires in-person)
• Issuing controlled substance prescriptions without checking the Texas Prescription Monitoring Program (PMP) first — mandatory for every controlled Rx

So a Texas psychiatrist can absolutely manage ADHD, anxiety, and other psychiatric conditions via telehealth, including prescribing stimulants and benzodiazepines. You just can’t manage chronic pain patients with opioids remotely.

For PMHNPs in Texas: You face significant restrictions. Texas does not allow independent NP practice — you must have a Prescriptive Authority Agreement with a physician. You generally cannot prescribe Schedule II controlled substances in outpatient settings (with very narrow exceptions like hospice). Most Texas PMHNPs rely on a supervising psychiatrist to write Schedule II prescriptions, or the psychiatrist handles those patients directly.

Texas also limits one physician to supervising 7 NPs/PAs at once, and requires monthly face-to-face meetings between the NP and physician for the first 3 years of the agreement. This makes scaling a Texas telehealth practice complex if you’re relying on PMHNPs.

New York: Recently Aligned State Rules with Federal Allowances

New York had a confusing patchwork of executive orders during COVID. In mid-2025, the state finalized regulations that align New York’s controlled substance prescribing rules with federal law — meaning whatever the DEA allows, New York allows.

For psychiatrists:

• You can prescribe controlled substances via telehealth under the current DEA waiver
• Once federal waivers end, New York’s rule includes exceptions: if another provider saw the patient in-person in the past 12 months, or if the prescription is for a short-term emergency, you can still prescribe remotely
• New York mandates e-prescribing (no paper scripts for controlled substances) and requires checking the state PMP (I-STOP database) before prescribing Schedule II-IV drugs

For PMHNPs in New York: New York is provider-friendly. After 3,600 hours of supervised practice (about 2 years), PMHNPs can practice independently — no ongoing physician oversight required. They just need a ‘collaborative relationship’ (informal consultation arrangement) rather than a formal supervising physician. Experienced NY PMHNPs have essentially the same prescribing authority as psychiatrists.

California: Transitioning to NP Independence, Strong Telehealth Support

California allows prescribing via telehealth as long as a ‘good faith exam’ is conducted — and video visits qualify. No special restrictions on controlled substances beyond federal law.

For psychiatrists: Full authority to prescribe anything via telehealth, as long as you use California’s CURES (PMP) database before prescribing Schedule II-IV drugs.

For PMHNPs: California is in transition. Under AB 890 (2020):

• As of January 2023, NPs with 3+ years experience can practice in certain settings without direct physician supervision (‘103 NP’ certification)
• As of January 2026, those NPs can apply for full independent practice authority (‘104 NP’), allowing them to prescribe independently even outside group settings

New graduate PMHNPs in California still need physician-supervised ‘standardized procedures’ for at least 3 years, but the state is clearly moving toward NP independence.

Pennsylvania: Still Requires Collaborative Agreements

Pennsylvania has not yet passed full practice authority for NPs. PMHNPs must have a collaborative agreement with a physician indefinitely — no pathway to independence as of 2026.

Pennsylvania NPs can prescribe controlled substances if the collaborating physician delegates it, but:

• Schedule II prescriptions are limited to 30-day supply for initial Rx
• Physician must be notified within 24 hours of prescribing Schedule II
• Physician must countersign a certain percentage of charts

Psychiatrists in PA practice independently and often serve as collaborators for PMHNPs (sometimes for a fee).

Illinois: Pathway to Independence After Experience

Illinois allows NPs to apply for Full Practice Authority after completing 4,000 hours of supervised practice (about 2 years) plus 250 hours of continuing education.

Until then, PMHNPs must practice under a Written Collaborative Agreement, and their prescriptions are technically under delegated authority (the physician’s name appears on scripts).

Once FPA is granted, Illinois PMHNPs can prescribe independently, including controlled substances, just like psychiatrists (with the caveat that they can’t prescribe opioids for chronic pain without physician consultation).

PMHNP vs. Psychiatrist Prescribing: Understanding the Scope Gap

If you’re a psychiatrist, your prescribing authority is straightforward: you can prescribe any medication within your competency, in any state where you hold a license, as long as you follow that state’s telehealth and controlled substance rules.

If you’re a PMHNP, your authority depends entirely on where your patient is located:

Full Practice Authority States (e.g., Washington, Oregon, Arizona, New Mexico, Colorado, Minnesota, Alaska, Hawaii, Idaho, Montana, Wyoming, North Dakota, South Dakota, Nebraska, Iowa, Wisconsin, Michigan, Vermont, New Hampshire, Maine, Rhode Island, Connecticut, Maryland, DC): You can practice and prescribe independently, including controlled substances, without physician oversight.

Reduced Practice States (e.g., New York, Illinois, California transitioning): You need physician collaboration initially, but can earn independence after meeting experience requirements.

Restricted Practice States (e.g., Texas, Florida for psych NPs, Georgia, Alabama, Tennessee, Missouri, Mississippi, South Carolina, North Carolina): You must have ongoing physician supervision or delegation to prescribe. In some states (like Texas), you cannot prescribe Schedule II controlled substances at all in outpatient settings.

This creates real headaches for telehealth platforms operating in multiple states. You can’t just hire a PMHNP and assume they can treat patients nationwide — you need to map their scope state-by-state and ensure physician oversight where required.

Collaborative Agreements: What They Actually Entail

In states requiring collaboration, the agreement isn’t just paperwork — it’s a legally binding document that governs what the PMHNP can do. Typical requirements include:

• Defined scope: Which medications can the NP prescribe? Can they prescribe Schedule II stimulants? Do they need physician approval for certain drug classes?
• Physician availability: How quickly must the physician respond to consults? What’s the backup plan if the physician is unavailable?
• Chart review: Many states require the physician to review a certain percentage of the NP’s charts monthly (often 10% or more)
• Meetings: Some states mandate regular face-to-face meetings (Texas requires monthly meetings for the first 3 years, then quarterly)
• State filing: Some states (like Kentucky) require filing the agreement with the nursing or medical board

Cost implications: Many physicians charge PMHNPs $500-$2,000+ per month for collaboration, which cuts into the NP’s income. Finding a collaborating psychiatrist in underserved areas can also be difficult — if you’re a Florida PMHNP, state law requires your collaborator to be a psychiatrist (not just any physician) to prescribe psychotropic controlled substances.

For telehealth practices, maintaining compliant collaborative agreements across multiple states is a major administrative burden. Many platforms solve this by employing supervising psychiatrists who collaborate with multiple NPs, or by only hiring providers in full-practice states.

Reimbursement: How Medication Management Gets Paid

Understanding reimbursement is critical — you can’t build a sustainable practice without knowing what you’ll actually collect per visit.

Medicare Rates (2026)

Medicare is the benchmark. For 2026, national average reimbursement for common psychiatric codes:

• 90792 (Initial psychiatric evaluation with medical services, ~60 min): $173
• 99213 (Established patient, 15-min med check): $92-$96
• 99214 (Established patient, 25-min med check): $125-$136
• 99215 (Established patient, 40+ min, complex): $192

Important: Medicare pays NPs at 85% of physician rates when billed under the NP’s own NPI. So if you’re a PMHNP seeing Medicare patients via telehealth, you’d get about $81 for a 99213 instead of $95.

Private Insurance

Commercial payers often pay more than Medicare, but rates vary widely. In high cost-of-living areas, a psychiatrist might get $150 for a 99213 and $200 for a 99214. In rural areas, it might be closer to Medicare rates.

Telehealth parity: Many states now require private insurers to pay the same for telehealth as in-person for mental health services. Illinois, California, and New York have strong parity laws. Texas requires coverage but doesn’t mandate equal payment (though many insurers voluntarily pay equal rates).

Medicaid

Medicaid pays less per visit (often $60-$80 for a 15-minute med check), but Medicaid programs increasingly cover telepsychiatry at parity with in-person. New York Medicaid, for example, has reimbursed tele-mental health equally since before COVID.

Some states have also started paying for audio-only mental health services via telephone, recognizing that some patients lack video access. Medicare pays the same for audio-only mental health visits as it does for video (through 2024 at least).

Cash Pay and Membership Models

Many telepsychiatrists skip insurance entirely and charge cash: $100-$200 per visit for med checks, $250-$400 for initial evaluations. This simplifies billing but limits patient access to those who can afford it.

Some platforms use hybrid models: insurance for medication management, cash for therapy or other services.

The Economics of Patient Acquisition in Telepsychiatry

Here’s where most provider marketing content gets it wrong: they claim you can acquire patients for ‘$30-50 each’ through DIY marketing. That’s fiction.

Reality check: Acquiring a qualified psychiatric patient through traditional marketing typically costs $200-500+ when you factor in:

• Agency or consultant fees for SEO, Google Ads, or content marketing
• Months of investment before SEO generates meaningful traffic (6-12 months minimum)
• Google Ads costs ($15-40+ per click for mental health keywords; most clicks don’t book)
• Directory listings (Psychology Today, Zocdoc) with monthly fees + per-booking charges
• Staff time to qualify leads and handle no-shows from cold leads
• Failed campaigns and testing costs

SEO takes 6-12 months of consistent investment before it pays off. Most solo providers don’t have the expertise or patience for this.

Google Ads for ‘psychiatrist near me’ or ‘ADHD doctor’ are expensive. You might pay $30 per click, and only 5-10% of clicks convert to booked patients — that’s $300-600 cost per booked patient. Then factor in no-shows (20-30% for cold leads) and your actual cost per seen patient is even higher.

Directory listings like Psychology Today charge $29.95/month, but you’re competing with hundreds of other providers on the same page. Zocdoc charges per booking ($35-100+ depending on market), plus monthly subscription fees. If you’re paying $500/month total and booking 10 patients, that’s $50 per lead — but again, not all leads show up or convert to ongoing patients.

Add it all up: $3,000-5,000/month in marketing spend with uncertain results vs. a platform that charges a standard fee per qualified patient who actually books with you.

Why Platforms Like Klarity Make Economic Sense

Klarity Health uses a pay-per-appointment model — you only pay when a qualified patient books with you. No upfront marketing spend. No monthly subscription fees. No wasted ad spend on clicks that don’t convert.

Compare the models:

DIY Marketing:

• $3,000-5,000/month in marketing spend
• 6-12 months before ROI
• You handle lead qualification, scheduling, no-shows
• Uncertain volume month-to-month

Klarity Model:

• Standard listing fee per new patient lead (similar to Zocdoc’s booking fee model)
• Patients are pre-qualified and matched to your specialty and availability
• Built-in telehealth infrastructure (no separate platform costs)
• You control your schedule — only pay when you see patients
• Both insurance and cash-pay patient flow

The value proposition: Instead of gambling $4,000/month on marketing channels that might work, you pay only when a patient actually shows up. That’s guaranteed ROI. Every dollar you spend directly generates a patient visit.

For providers starting out or scaling, this removes all the risk. You’re not spending your evenings learning Google Ads or paying an SEO agency $2,000/month for 6 months before seeing results.

And because Klarity handles credentialing, billing infrastructure (if insurance-based), and patient acquisition, you can focus entirely on clinical care — not running a marketing agency.

Practical Compliance Tips for Teleprescribing

Whether you join a platform or build your own practice, here’s what you need to do to stay compliant:

1. Get licensed in every state where your patients are located

You can’t treat a patient in Florida with only a Texas license, even if it’s via video. The Interstate Medical Licensure Compact (IMLC) makes this easier for physicians — Texas, Pennsylvania, and Illinois are members. New York, Florida, and California are not, so you’ll need to apply the traditional way for those licenses.

2. Use a HIPAA-compliant video platform

Zoom for Healthcare, Doxy.me, VSee, SimplePractice — these are acceptable. Regular Zoom or Skype are not.

3. Check your state’s Prescription Monitoring Program (PMP) before prescribing controlled substances

This is mandatory in most states. In Texas, you must check the PMP before every controlled substance prescription. In California, you must check at least once every 4 months for ongoing therapy.

4. Document the patient’s location and consent

Your notes should include: ‘Patient confirmed they are located in [State] at the time of this visit. Verbal consent obtained for telehealth services, including discussion of limitations and confidentiality.’

5. Have an emergency plan

What happens if a suicidal patient disconnects? You need a documented protocol: emergency contact information, local emergency resources, etc. Some states explicitly require this.

6. Use e-prescribing for controlled substances

Many states (like New York) mandate electronic prescribing for controlled substances. Even if not required, it’s best practice and reduces DEA scrutiny.

7. If you’re a PMHNP, ensure your collaborative agreement covers your scope

Don’t assume your agreement allows you to prescribe stimulants or benzodiazepines — check explicitly. If you’re treating patients in multiple states, you may need separate agreements for each state (or one agreement that covers multistate practice, if allowed).

8. Stay updated on DEA rule changes

Subscribe to DEA announcements, check the Center for Connected Health Policy’s state law database, and follow professional organizations (APA, AANP, state medical boards). The regulatory landscape is fluid.

The Future: What’s Coming in Telepsychiatry Prescribing

As of early 2026, the federal telehealth waivers remain in effect through December 31, 2025. The DEA has proposed permanent rules but hasn’t finalized them. Most observers expect some version of the following:

• Requirement for an in-person visit with some provider (not necessarily the prescriber) within the past 12 months, OR
• 30-day supply limit on initial controlled substance prescriptions via telehealth, OR
• Special DEA registration for telehealth prescribers (possibly with added training or oversight)

Congress has shown bipartisan support for extending telehealth flexibilities for mental health, so the most likely outcome is a hybrid: some modest restrictions (like the 12-month in-person visit rule) but continued ability to prescribe controlled substances remotely in most cases.

State-level trends: More states are moving toward full practice authority for NPs. Since 2020, over a dozen states (Massachusetts, Kansas, Indiana, Louisiana, Michigan, etc.) have granted NPs independence. Expect this trend to continue, particularly as psychiatrist shortages worsen.

Reimbursement: Telehealth parity laws are becoming permanent in most states. Medicare has committed to covering tele-mental health indefinitely (with minor requirements like occasional in-person visits for some patients). This creates a stable foundation for telehealth psychiatry going forward.

Bottom Line: Telehealth Prescribing Is Here to Stay

Can psychiatrists prescribe medication via telehealth? Absolutely. The infrastructure, legal framework, and reimbursement mechanisms are all in place. You can conduct comprehensive psychiatric evaluations, manage medication for depression, anxiety, ADHD, bipolar disorder, and more — all via video visit.

The barriers aren’t technological or clinical — they’re regulatory and logistical. Understanding your state’s rules, ensuring proper licensure, and navigating collaborative agreement requirements (if you’re a PMHNP) are the real challenges.

And then there’s patient acquisition. You can spend months and thousands of dollars building a marketing engine from scratch, or you can join a platform like Klarity Health that handles patient acquisition for you, with a pay-per-appointment model that eliminates upfront risk.

If you’re a psychiatrist or PMHNP looking to scale your practice via telehealth, the opportunity is enormous. The demand for psychiatric care far exceeds supply — every state faces provider shortages, with hundreds of thousands of patients unable to access care.

By leveraging telehealth and joining a platform that brings patients directly to you, you can double or triple your patient volume without doubling your overhead. You’ll spend less time on marketing and administration, and more time doing what you were trained to do: providing excellent psychiatric care.

Ready to explore what telehealth could do for your practice? Learn more about joining Klarity Health’s provider network and start seeing patients on your own schedule — without the marketing headaches or financial risk of going it alone.

Frequently Asked Questions

Can I prescribe Adderall or other ADHD stimulants via telehealth?

Yes, under current federal waivers (through December 31, 2025), you can prescribe Schedule II stimulants like Adderall, Ritalin, or Vyvanse to new patients via telehealth without an initial in-person visit. You must conduct a thorough video evaluation that meets the standard of care, check your state’s prescription monitoring program, and follow all state-specific rules. Some states (like Texas for NPs) have additional restrictions, so verify your specific scope of practice.

Do I need a separate DEA license for each state to prescribe controlled substances?

No. Your DEA registration is federal and tied to your practice location(s). However, you must hold a valid medical license in the state where your patient is located at the time of the telehealth visit. Some states require you to register your practice address with the state’s controlled substance authority, but you don’t need multiple DEA numbers for telehealth across states.

What happens when the federal telehealth waivers expire?

The DEA has proposed new rules that would likely require either: (1) an in-person visit with some provider within the past 12 months, (2) limiting initial telehealth prescriptions to 30 days, or (3) special DEA registration for telehealth prescribing. The exact requirements aren’t finalized as of early 2026. Most expect Congress to extend flexibilities for mental health, given strong bipartisan support and the ongoing provider shortage.

Can PMHNPs prescribe the same medications as psychiatrists?

It depends on the state. In full practice authority states (about 34 states as of 2025), PMHNPs can prescribe the same medications as psychiatrists, including controlled substances. In restricted states like Texas and Florida (for psych NPs), PMHNPs face limitations: they may need physician delegation to prescribe, cannot prescribe certain controlled substances, or must maintain ongoing collaborative agreements. Always check your state’s specific nursing practice act.

How do I handle emergencies during a telehealth visit?

Have a documented protocol: obtain emergency contact information and the patient’s physical location at the start of every visit, identify local emergency resources (nearest ER, crisis hotline numbers), and have a plan for what to do if the patient disconnects during a crisis. Many states require this as part of telehealth compliance. If a patient is imminently suicidal or homicidal, don’t hesitate to call 911 on their behalf.

Do insurance companies pay the same for telehealth as in-person visits?

For mental health services, yes — in most states. Over 40 states have telehealth parity laws requiring private insurers to cover (and often reimburse equally) telehealth mental health services. Medicare pays the same for tele-mental health as in-person through at least 2024. A few states (like Texas) don’t mandate payment parity, but most insurers voluntarily pay equal rates for psychiatric visits. Always verify with each payer’s specific policies.

What’s the difference between ‘incident to’ billing and billing under an NP’s own NPI?

‘Incident to’ billing allows an NP’s service to be billed under a physician’s NPI at 100% of the physician fee schedule, but it requires the physician to be physically present in the office suite (direct supervision). This doesn’t work for telehealth. When a PMHNP sees a patient via telehealth, they must bill under their own NPI, which Medicare reimburses at 85% of the physician rate. Some private insurers pay NPs at the same rate as physicians; others pay 85-90%.

Can I prescribe buprenorphine (Suboxone) for opioid use disorder via telehealth?

Yes. The X-waiver requirement was eliminated in 2023, so any DEA-registered provider can prescribe buprenorphine without additional training or waiver. Under current federal telehealth flexibilities, you can initiate buprenorphine via telehealth without an in-person visit. However, always follow your state’s specific opioid treatment program regulations and ensure you’re competent in addiction psychiatry or have appropriate training.

Do I need malpractice insurance that covers telehealth?

Absolutely. Most malpractice policies now include telehealth coverage, but verify this explicitly with your insurer. Some older policies may exclude telehealth or limit coverage to certain states. If you’re practicing in multiple states via telehealth, ensure your policy covers you in all those jurisdictions. Tail coverage is also important if you switch jobs or retire.

References and Sources

1. California Board of Registered Nursing – AB 890 Implementation FAQs. www.rn.ca.gov/practice/ab890.shtml (Updated November 2023). Official state regulatory guidance on NP practice authority transition.

2. Texas Board of Nursing – Advanced Practice Registered Nurse Practice FAQ. www.bon.texas.gov/faqpracticeaprn.asp.html (Revised 2021). Primary source for Texas NP scope and prescriptive authority requirements.

3. Zivian Health – ‘2026 NP-Physician Collaboration Regulations: Your Compliance Roadmap.’ www.zivianhealth.com/blog/np-physician-collaboration-regulations-your-compliance-roadmap (February 16, 2026). Comprehensive state-by-state analysis of collaborative practice agreements.

4. Center for Connected Health Policy – Texas Telehealth Laws. www.cchpca.org/texas (Updated January 19, 2026). Authoritative 50-state telehealth policy database.

5. National Law Review – ‘Telehealth and In-Person Visits: Tracking Federal and State Updates Post-Pandemic Era.’ natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era (August 15, 2025). Legal analysis of federal DEA waivers and state telehealth prescribing rules.

Source:

• https://www.bon.texas.gov/faqpracticeaprn.asp.html#:~:text=certificate%20or%20fetal%20death%20certificate,For%20additional%20information
• https://www.npschools.com/blog/guide-to-np-practice-in-florida#:~:text=match%20at%20L200%20%E2%80%9CUnder%20HB,%E2%80%9D
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era#:~:text=In%20late%202024%2C%20the%20U,prescribing
• https://www.flsenate.gov/laws/statutes/2024/464.012#:~:text=,the%20treatment%20of%20mental%20disorders
• https://www.cchpca.org/texas/#:~:text=including%2C%20but%20not%20limited%20to%2C,Code%2C%20Chapters%20481%20and%20483
• https://www.cchpca.org/texas/#:~:text=,way%20communication
• https://www.nursepractitioneronline.com/articles/nurse-practitioner-practice-authority-updates/#:~:text=As%20of%202025%2C%20the%20distribution,toward%20greater%20autonomy%20for%20NPs
• https://www.nursepractitioneronline.com/articles/nurse-practitioner-practice-authority-updates/#:~:text=,Michigan%20%282025
• https://www.pacnp.org/general/custom.asp?page=ScopeofPractice#:~:text=tests%2C%20and%20deliver%20other%20health,appropriate%20experience%20can%20receive%20a
• https://www.jdsupra.com/legalnews/new-law-allows-experienced-nps-to-8292796/#:~:text=New%20York%E2%80%99s%202023%20state%20budget%2C,practice%20without%20a%20collaborative%20relationship